Atlas Trials

Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus

Clinical trial NCT00611663 · COMPLETED

Trial details

NCT number
NCT00611663
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lupus Erythematosus, Systemic
Start date
2008-05-01
Primary completion
2014-12-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.